Page last updated: 2024-09-03

val-leu-arg-p-nitroanilide and valyl-leucyl-lysine 4-nitroanilide

val-leu-arg-p-nitroanilide has been researched along with valyl-leucyl-lysine 4-nitroanilide in 2 studies

Compound Research Comparison

Studies
(val-leu-arg-p-nitroanilide)
Trials
(val-leu-arg-p-nitroanilide)
Recent Studies (post-2010)
(val-leu-arg-p-nitroanilide)
Studies
(valyl-leucyl-lysine 4-nitroanilide)
Trials
(valyl-leucyl-lysine 4-nitroanilide)
Recent Studies (post-2010) (valyl-leucyl-lysine 4-nitroanilide)
28009901

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Long, WF; Williamson, FB1
Bittar, ER; Figueiredo, AF; Maia, CN; Miranda, TL; Santoro, MM; Sousa, MO1

Other Studies

2 other study(ies) available for val-leu-arg-p-nitroanilide and valyl-leucyl-lysine 4-nitroanilide

ArticleYear
Effect of antithrombin III, alpha 1-proteinase inhibitor and heparin on amidolytic activity of nerve growth factor (7S-NGF).
    Biochemical and biophysical research communications, 1983, May-31, Volume: 113, Issue:1

    Topics: alpha 1-Antitrypsin; Animals; Antithrombin III; Blood Proteins; Cattle; Dipeptides; Heparin; Kallikreins; Mice; Nerve Growth Factors; Oligopeptides; Thrombin

1983
Kinetic peculiarities of human tissue kallikrein: 1--substrate activation in the catalyzed hydrolysis of H-D-valyl-L-leucyl-L-arginine 4-nitroanilide and H-D-valyl-L-leucyl-L-lysine 4-nitroanilide; 2--substrate inhibition in the catalyzed hydrolysis of N
    Archives of biochemistry and biophysics, 2002, Apr-01, Volume: 400, Issue:1

    Topics: Catalysis; Chromogenic Compounds; Humans; Hydrolysis; Kallikreins; Kinetics; Models, Chemical; Oligopeptides; Protein Binding; Substrate Specificity; Tosylarginine Methyl Ester

2002